Analgesics⏵
Antiandrogens⏵
Antihistamines⏵
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle⏵
Melatonin
Metformin
Minerals⏵
Monoclonals⏵
Mpro inhibitors⏵
Naso/orophar..⏵
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors⏵
TMPRSS2 inh.⏵
Thermotherapy
Vitamins⏵
More⏵

Other
Feedback
Home
 
Top
..
Sort alphabetically
..
Feedback
Home
c19early.org COVID-19 treatment researchSelect treatment..Select..
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta
Home Adoption Other Treatments
@CovidAnalysis

Early treatments for COVID-19

Home
@CovidAnalysis
Submit
Updates
The 9,436 treatments below have been reported as potentially beneficial for COVID-19. We currently review studies for:
acebilustat  acetaminophen  adalimumab  adintrevimab  alkalinization  amantadine  amiodarone  ammonium chloride  amubarvimab  andrographolide  antiandrogens  antihistamine H1RAs  apremilast  artemisinin  aspirin  astodrimer sodium  atilotrelvir  atovaquone  avdoralimab  aviptadil  azelastine  azvudine  baloxavir  bamlanivimab/etesevimab  bebtelovimab  belnacasan  bemnifosbuvir  beta-glucans  BMS mAbs  brensocatib  brexanolone  bromhexine  budesonide  camostat  cannabidiol  casirivimab/imdevimab  cenicriviroc  cetylpyridinium chloride  chlorhexidine  chlorpheniramine  CK0802  clevudine  colchicine  convalescent plasma  crizanlizumab  curcumin  cytokine adsorption  danicopan  darunavir  deuremidevir  dexamethasone  DFV890  diet  dolutegravir  donidalorsen  dornase alfa  edaravone  empagliflozin  emvododstat  enisamium  ensitrelvir  ensovibep  estetrol  exercise  famotidine  favipiravir  fluvoxamine  FX06  gabapentin  GB0139  gimsilumab  glenzocimab  goflikicept  HCQ  hesperidin  HH-120  HuMax-IL8  hydrogen peroxide  ibrutinib  ibuprofen  ibuzatrelvir  iC1e/K  indomethacin  interleukin-2  iota-carrageenan  ivermectin  ixekizumab  lactoferrin  lanadelumab  leritrelvir  levilimab  losartan  lufotrelvir  MAS825  mebendazole  mefenamic acid  melatonin  metformin  metronidazole  molnupiravir  montelukast  N-acetylcysteine  nafamostat  niclosamide  nicotine  nigella sativa  nitazoxanide  nitric oxide  olokizumab  pacritinib  paxlovid  peginterferon lambda  pemivibart  pentoxifylline  pHOXWELL  phthalocyanine  plasma-activated water  plitidepsin  pomotrelvir  posaconazole  povidone-iodine  PPE  probiotics  propolis  proton pump inhibitors  proxalutamide  quercetin  ravulizumab  razuprotafib  regdanvimab  remdesivir  resveratrol  rhu-pGSN  rNAPc2  SA58  sargramostim  sarilumab  selenium  sentinox  siltuximab  silymarin  sipavibart  sleep  SNS812  sodium bicarbonate  sotrovimab  spironolactone  sunlight  thermotherapy  tixagevimab/cilgavimab  TMPRSS2 inhibitors  tocilizumab  trimodulin  TRV027  ursodeoxycholic acid  vadadustat  varespladib  verapamil  vidofludimus calcium  vilobelimab  vitamin A  vitamin B12  vitamin B9  vitamin C  vitamin D  vitamin K  XAV-19  xiannuoxin  zafirlukast  zenuzolac  zinc  zunsemetinib 
Potential benefits of 9,264 other treatments have been reported. We have not reviewed these studies.
Sort by number of studies   Sort alphabetically   Submit updates
(-)-epigallocatechin gallate (4 studies)
(-)-epicatechin 3-O-caffeoate (2 studies)
(-)-epigallocatechin 3-gallate (2 studies)
(+,-) Octopamine HCl (1 study)
(-)-anisomelic acid (1 study)
(-)-Catechin gallate (1 study)
(-)-epiafzelechin 3-O-gallate (1 study)
(-)-epicatechin-3-0-gallate (1 study)
(-)-epicatechin-3-o-gallate (1 study)
(-)-epicatechin gallate (1 study)
(-)-epigallocatechin (1 study)
(-)-epigallocatechin-3-o-gallate (1 study)
(-)-Eseroline (1 study)
(-)-gallocatechin-3-o-gallate (1 study)
(-)-gallocatechin gallate (1 study)
(-)-hopeaphenol (1 study)
(-)-jasmonic acid (1 study)
(±)-lespeol (1 study)
2-monolinolenin (1 study)
α-/β-punicalin (1 study)
arsenite(3-) (1 study)
cladosin C (1 study)
COV44-62 (1 study)
CR-31-B-(-) (1 study)
hydroxytyrosol (1 study)
Jun9-62-2R (1 study)
N-0385 (1 study)
Qing Yan He Ji (1 study)
quadranoside-III (1 study)
(R)-(-)-LY 426965 dihydrochloride (1 study)
R(-)-2-Hydroxyapomorphine (1 study)
R(-)-2-OH-NPA (1 study)
R(-)-N-Allylnorapomorphine (1 study)
R(-)-NPA (1 study)
Siparuna glycycarpa (1 study)
Thymbra capitata (1 study)
Triazavirin - riamilovir (1 study)
ursolic acid (1 study)
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0